Search Results - "Yijun Fan, Kevin"
-
1
Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey
Published in Current oncology (Toronto) (01-05-2024)“…Small-cell neuroendocrine carcinoma of the cervix (SCNECC) is a rare cancer with poor prognosis, with limited data to guide its treatment. The objective of…”
Get full text
Journal Article -
2
Practice patterns in the treatment of small cell carcinoma of the cervix: Analysis of a Canadian multidisciplinary survey
Published in Gynecologic oncology (01-11-2024)Get full text
Journal Article -
3
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy
Published in Journal of neuro-oncology (04-10-2024)“…In patients with oligometastatic disease (OMD) treated with stereotactic body radiation therapy (SBRT), those who develop brain metastases (BrM) may have poor…”
Get full text
Journal Article -
4
BMRK-05 ASSOCIATION BETWEEN HER2-LOW STATUS AND TIME TO DEVELOPMENT OF BRAIN METASTASES AMONG PATIENTS WITH BREAST CANCER: A RETROSPECTIVE COHORT STUDY
Published in Neuro-oncology advances (02-08-2024)“…Abstract BACKGROUND Brain metastases (BrM) develop in a high proportion of patients with breast cancer. We aimed to investigate the association between HER2…”
Get full text
Journal Article -
5
Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
Published in Cancers (13-05-2023)“…We aimed to evaluate the expression of the "targetable" androgen receptor (AR) in breast cancer brain metastases (BrM). An established, retrospective…”
Get full text
Journal Article -
6
EXPRESSION OF ANDROGEN RECEPTOR IN BREAST CANCER BRAIN METASTASES
Published in Neuro-oncology advances (12-07-2023)“…Abstract Given availability of central nervous system (CNS)-penetrant systemic therapies that target the androgen receptor (AR), we evaluated the expression of…”
Get full text
Journal Article -
7
Human Epidermal Growth Factor Receptor 2-Low Breast Cancer Brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population
Published in JCO precision oncology (01-03-2024)“…Trastuzumab deruxtecan is a new treatment option for patients with advanced human epidermal growth factor receptor 2 (HER2)-low breast cancer (BC). Although…”
Get more information
Journal Article -
8
Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy
Published in Journal of neuro-oncology (2021)“…Introduction This study aimed to investigate whether systemic therapy (ST) use surrounding radiation therapy (RT) predicts overall survival (OS) after RT for…”
Get full text
Journal Article -
9
BMRK-04 EFFECT OF PRIMARY CANCER SITE AND EXTRACRANIAL PROGRESSION ON DEVELOPMENT OF BRAIN METASTASES IN PATIENTS TREATED WITH STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC SOLID TUMORS
Published in Neuro-oncology advances (02-08-2024)“…Abstract BACKGROUND Patients with oligometastatic disease (OMD) may achieve long-term control with stereotactic body radiation therapy (SBRT). However, those…”
Get full text
Journal Article